ID
13726
Beschrijving
A Randomized Study of Gemtuzumab Ozogamicin (GO) With Daunorubicine and Cytarabine in Untreated Acute Myeloid Leukemia (AML) Aged of 50-70 Years Old; ODM derived from: https://clinicaltrials.gov/show/NCT00927498
Link
https://clinicaltrials.gov/show/NCT00927498
Trefwoorden
Versies (1)
- 01-03-16 01-03-16 -
Houder van rechten
CC BY-NC 3.0
Geüploaded op
1 maart 2016
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY-NC 3.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Acute Myeloid Leukemia NCT00927498
Eligibility Acute Myeloid Leukemia NCT00927498
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
m3-aml
Datatype
boolean
Alias
- UMLS CUI [1]
- C0023487
Beschrijving
aml following previously know myeloproliferative syndrome.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0280449
- UMLS CUI [2,1]
- C1443043
- UMLS CUI [2,2]
- C0332152
Beschrijving
known central nervous system involvement.
Datatype
boolean
Alias
- UMLS CUI [1]
- C0449389
Beschrijving
uncontrolled infection
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009488
Beschrijving
other active malignancy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Acute Myeloid Leukemia NCT00927498
- StudyEvent: Eligibility
C0332155 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
C0019163 (UMLS CUI [2])
C0019196 (UMLS CUI [3])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C3831118 (UMLS CUI [2])
C1443043 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])